DANIEL KIRKLEY: Open Payments
NPI 1245748045 · INDIAN LAND, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 36 payments from 10 companies in 2025. Trend: 2023 $122 · 2024 $593 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $184 |
| Novo Nordisk Inc | 9 | $184 |
| Exact Sciences Corporation | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Amgen Inc. | 4 | $66 |
| PFIZER INC. | 1 | $27 |
| SHIELD THERAPEUTICS INC | 1 | $26 |
| Almatica Pharma LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: QULIPTA, Ozempic, Cologuard Collection Kit, Wegovy, VRAYLAR, AIRSUPRA, Rybelsus, UBRELVY.
Industry payments across SC — which companies pay providers there.
